Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension

Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension

Item
http://www.wikidata.org/entity/Q28292785
Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological targetRedox signaling, vascular function, and hypertension.Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromePharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?Matrix metalloproteinases as drug targets in preeclampsiaSerum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 DiabetesImbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.Matrix metalloproteinases: a target in in-stent restenosis?.Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.Lercanidipine in the Management of Hypertension: An Update.Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats.
P2860

Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension

Item
http://www.wikidata.org/entity/Q28292785
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@ast
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@en
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@nl
type
label
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@ast
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@en
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@nl
prefLabel
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@ast
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@en
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
@en
P2093
P304
P31
P3181
P356
10.1097/01.FJC.0000196241.96759.71
P407
P433
P478
P50
P577
P5875
P698
P921